Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001192482-19-000514
Filing Date
2019-12-12
Accepted
2019-12-12 10:43:27
Documents
1
Effectiveness Date
2019-12-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4833
  Complete submission text file 0001192482-19-000514.txt   5929
Mailing Address 3401 GRAYS FERRY AVENUE BUILDING 176-1032 PHILADELPHIA PA 19146
Business Address 3401 GRAYS FERRY AVENUE BUILDING 176-1032 PHILADELPHIA PA 19146 610-308-9229
Pinpoint Therapeutics Inc. (Filer) CIK: 0001796645 (see all company filings)

EIN.: 843776390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-355367 | Film No.: 191281282